Are you Dr. Tepper?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 61 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
53 Laurel Rd
Weston, MA 02493Phone+1 617-921-7042- Is this information wrong?
Summary
- Dr. Robert Tepper, MD is an oncologist in Weston, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 1986 - 1986
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1984 - 1985
- Massachusetts General HospitalResidency, Internal Medicine, 1981 - 1984
- Harvard Medical SchoolClass of 1981
Certifications & Licensure
- MA State Medical License 1983 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 113 citationsAn implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumorsOliver Jonas, Heather M. Landry, Jason Fuller, John T. Santini, José Baselga, Robert I. Tepper, Michael J. Cima, Robert Langer> ;Science Translational Medicine. 2015 Apr 22
- 71 citationsBirth cohorts in asthma and allergic diseases: Report of a NIAID/NHLBI/MeDALL joint workshopJean Bousquet, James E. Gern, Fernando D. Martinez, Josep M. Antó, Christine Haynes Johnson, Patrick G. Holt, Robert F. Lemanske, Peter N. Le Souëf, Robert I. Tepper, ...> ;The Journal of Allergy and Clinical Immunology. 2014 Jun 1
- 26 citationsThumb replantation: a retrospective review of 103 cases.Sheel Sharma, S. Lin, A. Panozzo, Robert I. Tepper, D. Friedman> ;Annals of Plastic Surgery. 2005 Oct 1
- Join now to see all
Press Mentions
- Chutes & Ladders: Teva Appoints New CLO Amid DOJ's Price Collusion InvestigationNovember 10th, 2016
- Neon Therapeutics Appoints Dr. Richard Gaynor to President of Research and DevelopmentNovember 7th, 2016